Becton Dickinson Gross Margin 2010-2023 | BDX

Current and historical gross margin for Becton Dickinson (BDX) over the last 10 years. The current gross profit margin for Becton Dickinson as of December 31, 2023 is %.
Becton Dickinson Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-12-31 $19.49B $8.06B 41.37%
2023-09-30 $19.37B $8.17B 42.17%
2023-06-30 $19.05B $8.55B 44.87%
2023-03-31 $18.81B $8.51B 45.25%
2022-12-31 $18.74B $8.39B 44.78%
2022-09-30 $18.87B $8.48B 44.92%
2022-06-30 $18.41B $8.10B 43.97%
2022-03-31 $18.38B $7.99B 43.46%
2021-12-31 $18.53B $8.12B 43.81%
2021-09-30 $19.13B $8.63B 45.12%
2021-06-30 $18.57B $8.36B 45.04%
2021-03-31 $17.82B $8.07B 45.26%
2020-12-31 $17.16B $7.55B 44.00%
2020-09-30 $16.07B $6.80B 42.29%
2020-06-30 $16.92B $7.64B 45.15%
2020-03-31 $17.41B $8.05B 46.24%
2019-12-31 $17.36B $8.29B 47.78%
2019-09-30 $17.29B $8.29B 47.94%
2019-06-30 $17.11B $8.12B 47.43%
2019-03-31 $17.04B $8.06B 47.29%
2018-12-31 $17.06B $7.69B 45.06%
2018-09-30 $15.98B $7.27B 45.48%
2018-06-30 $14.75B $6.75B 45.79%
2018-03-31 $13.50B $6.24B 46.21%
2017-12-31 $12.25B $6.07B 49.51%
2017-09-30 $12.09B $5.97B 49.33%
2017-06-30 $12.16B $5.94B 48.86%
2017-03-31 $12.32B $5.98B 48.57%
2016-12-31 $12.42B $6.04B 48.59%
2016-09-30 $12.48B $5.99B 47.99%
2016-06-30 $12.31B $5.87B 47.66%
2016-03-31 $12.23B $5.50B 44.92%
2015-12-31 $11.22B $5.06B 45.09%
2015-09-30 $10.28B $4.70B 45.66%
2015-06-30 $9.42B $4.37B 46.34%
2015-03-31 $8.46B $4.30B 50.87%
2014-12-31 $8.48B $4.31B 50.83%
2014-09-30 $8.45B $4.30B 50.92%
2014-06-30 $8.35B $4.29B 51.36%
2014-03-31 $8.24B $4.24B 51.39%
2013-12-31 $8.17B $4.20B 51.41%
2013-09-30 $8.05B $4.17B 51.79%
2013-06-30 $7.92B $4.09B 51.58%
2013-03-31 $7.85B $4.06B 51.71%
2012-12-31 $7.78B $4.03B 51.79%
2012-09-30 $7.71B $3.95B 51.28%
2012-06-30 $7.61B $3.90B 51.30%
2012-03-31 $7.58B $3.90B 51.44%
2011-12-31 $7.57B $3.91B 51.66%
2011-09-30 $7.58B $3.96B 52.20%
2011-06-30 $7.34B $3.85B 52.39%
2011-03-31 $7.22B $3.76B 52.13%
2010-12-31 $7.10B $3.70B 52.11%
2010-09-30 $7.12B $3.70B 51.87%
2010-06-30 $7.22B $3.75B 51.97%
2010-03-31 $7.21B $3.77B 52.23%
2009-12-31 $7.14B $3.73B 52.23%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.638B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00